Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria

IF 22.5 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2024-09-19 DOI:10.1001/jamaoncol.2024.3888

Dominik Hlauschek, Christian Fesl, Michael Gnant

引用次数: 0

Abstract

This Viewpoint discusses how the inclusion or exclusion of certain events in the standardization of clinical trial end points can affect the interpretation of results.

查看原文本刊更多论文

辅助试验疗效终点的标准化定义--最新的 STEEP 标准

本视点讨论了在临床试验终点标准化中纳入或排除某些事件会如何影响结果的解释。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.